Attenuation of cerebral ischemic injury in Smad1 deficient mice

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Wong, Jamie K ^a   Chen, Lei ^a   Huang, Yong ^a   Sehba, Fatima A ^a   Friedel, Roland H ^a   Zou, Hongyan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; SMAD1 PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; PROTEIN P53; SMAD1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN CELL; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN REGION; CELL ACTIVATION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CORPUS STRIATUM; FRONTAL CORTEX; FRONTOPARIETAL CORTEX; HIPPOCAMPUS; IMMUNOREACTIVITY; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; UPREGULATION; ANIMAL; CELL CULTURE; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MICE; OXIDATIVE STRESS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84943329432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136967     Document Type: Article

References (49)

1. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nature medicine. 2011;17(7):796-808. doi: 10.1038/nm.2399 PMID: 21738161; PubMed Central PMCID: PMC3137275.
2. Sloan SA, Barres BA. The detrimental role of glial acidification during ischemia. Neuron. 2014;81(2):221-3. doi: 10.1016/j.neuron. 2013.12.032 PMID: 24462089.
3. Rossi DJ, Brady JD, Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci. 2007;10(11):1377-86. Epub 2007/10/30. nn2004 [pii] doi: 10.1038/nn2004 PMID: 17965658.
4. Chen Y, Vartiainen NE, Ying W, Chan PH, Koistinaho J, Swanson RA. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. Journal of neurochemistry. 2001;77(6):1601-10. Epub 2001/06/20. PMID: 11413243.
5. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685-700. PMID: 12809600.
6. Harvey BK, Hoffer BJ, Wang Y. Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Pharmacol Ther. 2005;105(2):113-25. Epub 2005/01/27. S0163-7258 (04) 00156-1 [pii] doi: 10.1016/j.pharmthera.2004.09.003 PMID: 15670622.
7. Shin JA, Kang JL, Lee KE, Park EM. Different temporal patterns in the expressions of bone morphogenetic proteins and noggin during astroglial scar formation after ischemic stroke. Cell Mol Neurobiol. 2012;32(4):587-97. Epub 2012/02/03. doi: 10.1007/s10571-012-9806-6 PMID: 22297545.
8. Pachori AS, Custer L, Hansen D, Clapp S, Kemppa E, Klingensmith J. Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway. Journal of molecular and cellular cardiology. 2010;48(6):1255-65. doi: 10.1016/j.yjmcc.2010.01.010 PMID: 20096288.
9. Sun B, Huo R, Sheng Y, Li Y, Xie X, Chen C, et al. Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy. Hypertension. 2013;61(2):352-60. Epub 2012/12/19. HYPERTENSIONAHA.111.00562 [pii] doi: 10.1161/HYPERTENSIONAHA.111.00562 PMID: 23248151.
10. Chau JF, Jia D, Wang Z, Liu Z, Hu Y, Zhang X, et al. A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response. Nature communications. 2012;3:836. doi: 10.1038/ncomms1832 PMID: 22588298.
11. Endo H, Kamada H, Nito C, Nishi T, Chan PH. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J Neurosci. 2006;26(30):7974-83. doi: 10.1523/JNEUROSCI.0897-06.2006 PMID: 16870742.
12. Li Y, Chopp M, Zhang ZG, Zaloga C, Niewenhuis L, Gautam S. p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke. 1994;25(4):849-55; discussion 55-6. PMID: 8160232.
13. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000;67(3):737-44. Epub 2000/07/25. S0002-9297 (07) 63259-5 [pii] doi: 10.1086/303059 PMID: 10903931; PubMed Central PMCID: PMC1287532.
14. Lories RJ, Luyten FP. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev. 2005;16(3):287-98. Epub 2005/07/05. S1359-6101 (05) 00048-1 [pii] doi: 10. 1016/j.cytogfr.2005.02.009 PMID: 15993360.
15. Rigelsky CM, Jennings C, Lehtonen R, Minai OA, Eng C, Aldred MA. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia. Am J Med Genet A. 2008;146 A (19):2551-6. Epub 2008/09/17. doi: 10.1002/ajmg.a.32468 PMID: 18792970.
16. Huang S, Tang B, Usoskin D, Lechleider RJ, Jamin SP, Li C, et al. Conditional knockout of the Smad1 gene. Genesis. 2002;32(2):76-9. Epub 2002/02/22. doi: 10.1002/gene.10059 [pii]. PMID: 11857782.
17. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nature genetics. 1999;23(1):99-103. doi: 10.1038/12703 PMID: 10471508.
18. Finelli MJ, Murphy KJ, Chen L, Zou H. Differential phosphorylation of Smad1 integrates BMPandneurotrophin pathways through Erk/Dusp in axon development. Cell reports. 2013;3(5):1592-606. doi: 10. 1016/j.celrep. 2013.04.011 PMID: 23665221; PubMed Central PMCID: PMC3677165.
19. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472-6. PMID: 3715945.
20. Zimmerman L, Parr B, Lendahl U, Cunningham M, McKay R, Gavin B, et al. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron. 1994;12(1):11-24. PMID: 8292356.
21. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O'Keeffe S, et al. An RNA-sequencingtranscriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34(36):11929-47. doi: 10.1523/JNEUROSCI.1860-14.2014 PMID: 25186741; PubMed Central PMCID: PMC4152602.
22. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta neuropathologica. 2010;119(1):7-35. Epub 2009/12/17. doi: 10.1007/s00401-009-0619-8 PMID: 20012068; PubMed Central PMCID: PMC2799634.
23. Deloulme JC, Raponi E, Gentil BJ, Bertacchi N, Marks A, Labourdette G, et al. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Mol Cell Neurosci. 2004;27(4):453-65. doi: 10. 1016/j.mcn. 2004.07.008 PMID: 15555923.
24. Wang DD, Bordey A. The astrocyte odyssey. Progress in neurobiology. 2008;86(4):342-67. doi: 10. 1016/j.pneurobio.2008.09.015 PMID: 18948166; PubMed Central PMCID: PMC2613184.
25. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci. 2006;7(6):437-48. doi: 10.1038/nrn1927 PMID: 16715053.
26. Zhang F, Chen J. Infarct Measurement in Focal Cerebral Ischemia: TTC Staining. Animal Models of Acute Neurological Injuries II, Springer Protocols Handbook. 2012:93-8.
27. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17(6):1304-8. PMID: 2433817.
28. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(6):2244-50. doi: 10. 1161/STROKEAHA.108.541128 PMID: 19246690; PubMed Central PMCID: PMC2888275.
29. Carmichael ST. Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann Neurol. 2006;59(5):735-42. Epub 2006/04/25. doi: 10.1002/ana.20845 PMID: 16634041.
30. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA. Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron. 1996;17(4):595-606. PMID: 8893018.
31. Ridder DA, Schwaninger M. NF-kappaB signaling in cerebral ischemia. Neuroscience. 2009;158(3):995-1006. doi: 10.1016/j.neuroscience.2008.07.007 PMID: 18675321.
32. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008;453(7196):807-11. doi: 10.1038/nature06905 PMID: 18432192; PubMed Central PMCID: PMC2669289.
33. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, et al. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci. 2003;23(8):3394-406. PMID: 12716947.
34. Zhang SJ, Zou M, Lu L, Lau D, Ditzel DA, Delucinge-Vivier C, et al. Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity. PLoS Genet. 2009;5(8):e1000604. doi: 10.1371/journal.pgen. 1000604 PMID: 19680447; PubMed Central PMCID: PMC2718706.
35. Smith J, Ladi E, Mayer-Proschel M, Noble M. Redoxstate is acentral modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci USA. 2000;97(18):10032-7. Epub 2000/08/16. doi: 10.1073/pnas.170209797 PMID: 10944195; PubMed Central PMCID: PMC27662.
36. Wong WT, Tian XY, Chen Y, Leung FP, Liu L, Lee HK, et al. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circ Res. 2010;107(8):984-91. Epub 2010/08/21. CIRCRESAHA.110.222794 [pii]doi: 10.1161/CIRCRESAHA.110.222794 PMID: 20724703.
37. Liberman M, Johnson RC, Handy DE, Loscalzo J, Leopold JA. Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys ResCommun. 2011;413(3):436-41. Epub 2011/09/13. S0006-291X (11) 01532-4 [pii] doi: 10.1016/j.bbrc.2011.08.114 PMID: 21907184; PubMed Central PMCID: PMC3197703.
38. Chuang DM, Wang Z, Chiu CT. GSK-3asaTargetfor Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke. Frontiers in molecular neuroscience. 2011;4:15. doi: 10.3389/fnmol.2011.00015 PMID: 21886605; PubMed Central PMCID: PMC3152742.
39. Ploughman M, Windle V, MacLellan CL, White N, Dore JJ, Corbett D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke. 2009;40(4):1490-5. doi: 10.1161/STROKEAHA. 108.531806 PMID: 19164786.
40. Samanta J, Alden T, Gobeske K, Kan L, Kessler JA. Noggin protects against ischemic brain injury in rodents. Stroke. 2010;41(2):357-62. Epub 2009/12/19. STROKEAHA.109.565523 [pii] doi: 10.1161/STROKEAHA.109.565523 PMID: 20019326; PubMed Central PMCID: PMC2822348.
41. Chen C, Cheng Y, Chen J. Transfection of Noggin in bone marrow stromal cells (BMSCs) enhances BMSC-induced functional outcome after stroke in rats. Journal of neuroscience research. 2011;89(8):1194-202. doi: 10.1002/jnr.22662 PMID: 21544853.
42. Chang CF, Lin SZ, Chiang YH, Morales M, Chou J, Lein P, et al. Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke. 2003;34(2):558-64. Epub 2003/02/08. PMID: 12574575.
43. Chou J, Harvey BK, Chang CF, Shen H, Morales M, Wang Y. Neuroregenerative effects of BMP7 after stroke in rats. J Neurol Sci. 2006;240(1-2):21-9. Epub 2005/10/21. S0022-510X (05) 00309-6 [pii] doi: 10.1016/j.jns.2005.08.015 PMID: 16236321.
44. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. NatChem Biol. 2008;4(1):33-41. Epub 2007/11/21. nchembio.2007.54 [pii] doi: 10.1038/nchembio.2007.54 PMID: 18026094.
45. Radermacher KA, Wingler K, Kleikers P, Altenhofer S, Hermans J Jr, Kleinschnitz C, et al. The 1027th target candidate in stroke: Will NADPH oxidase hold up? Experimental & translational stroke medicine. 2012;4(1):11. doi: 10.1186/2040-7378-4-11 PMID: 22625431; PubMed Central PMCID: PMC3403875.
46. Chan PH, Kawase M, Murakami K, Chen SF, Li Y, Calagui B, et al. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci. 1998;18(20):8292-9. PMID: 9763473.
47. Bell KF, Fowler JH, Al-Mubarak B, Horsburgh K, Hardingham GE. Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning. Oxid Med Cell Longev. 2011;2011:689524. Epub 2011/09/10. doi: 10.1155/2011/689524 PMID: 21904646; PubMed Central PMCID: PMC3166574.
48. Gupta K, Patani R, Baxter P, Serio A, Story D, Tsujita T, et al. Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell death and differentiation. 2012;19(5):779-87. Epub 2011/11/19. doi: 10.1038/cdd. 2011.154 PMID: 22095276; PubMed Central PMCID: PMC3321621.
49. Haskew-Layton RE, Payappilly JB, Smirnova NA, Ma TC, Chan KK, Murphy TH, et al. Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc Natl Acad Sci USA. 2010;107(40):17385-90. doi: 10.1073/pnas. 1003996107 PMID: 20855618; PubMed Central PMCID: PMC2951414.